About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Family Based Intervention in Childhood obesitY | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNANCT01110096

Family Based Intervention in Childhood obesitY

The study compares the effect on BMI of two different treatment options for obesity in childhood. Families with at least one obese child and parent are invited to join the project. The hypothesis is t...

Lead sponsor: Sykehuset i Vestfold HF•2 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Sykehuset i Vestfold HF

Collaborators

St. Olavs Hospital
Røros Rehabiliteringssenter
Oslo University Hospital
Evjeklinikken
Gjensidigestiftelsen
Stiftelsen Helse og Rehabilitering
Organisasjonen Voksne for Barn

Participants are randomised to two intervention groups: A): Two weeks family camp and two years follow-up as a cooperation with primary health care, private rehabilitation center and specialist health care. B): Four days lifestyle school with two years follow-up as a cooperation with primary health care and specialist health care

Age

7 - 11 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•age 7 to 12 years
•BMI \> iso-BMI 30 (Coles index)

Exclusion Criteria

•syndromatic obesity
•obesity related to diseases
•local community not involved
•child has present follow-up because of obesity in secondary health care
•parent has present/planned follow-up because of obesity in secondary health care

Related studies

Five PLus Year EffIcacy of Endoscopic Sleeve Gastroplasty (ESG) for Sustained WeigHT Loss

NCT06894498 · Obesity and Obesity-related Medical Conditions, Weight Loss

Intensive Glycemic Targets in Overweight and Obese Women With Gestational Diabetes

NCT05124808 · Gestational Diabetes, Pregnancy, High Risk, and more

RECRUITINGPhase 3

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

NCT06937086 · Ulcerative Colitis, Obesity or Overweight

RECRUITINGPhase 3

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

NCT07595549 · Obesity, Overweight and/or Obesity, and more

RECRUITINGPhase 3

Efficacy and Safety of KAI-9531 in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes

NCT07284875 · Obesity, Overweight

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: April 15, 2020Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment100

Start dateApr 2010

Last updatedApr 15, 2020

Condition

Locations shown

St Olavs Hospital

Trondheim

Morbid Obesity Center, The Hospital of Vestfold, South-Eastern Norway Regional Health Authority

Tønsberg

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 15, 2020Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions